Atlas Trials

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Clinical trial NCT03522441 · COMPLETED

Trial details

NCT number
NCT03522441
Sponsor
Akorn, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2018-04-27
Primary completion
2019-04-22
Enrollment
1125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.